Advanced Search
Contact | Corporate | Help

Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC

Sponsors:
  • Stanford University
  • Biogen Idec
  • Genentech
  • Aventis Pharmaceuticals
Phases:
  • Phase II
IndicationsAcronym:
  • Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Docetaxel
  • Drug: Carboplatin
  • Procedure: Radiation therapy
  • Procedure: Surgical resection
Enrollment:
30

Additional information about NCT00238615.


SourceSolution © 2008-2012